Clinical Trial Update: A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]

View source ↗

Summary

It is a Phase 3 study assessing the long-term safety and efficacy of povorcitinib in participants with moderate-to-severe hidradenitis suppurativa; the trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Povorcitinib (povorcitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Hidradenitis Suppurativa (HS) | Phase 3 | Status: ACTIVE_NOT_RECRUITING